A Toronto AI-Cardiac Diagnostics Company Just Cleared Three of the Hardest Validation Bars in Medtech

VentriPoint Diagnostics Ltd. (TSXV: VPT), a Toronto-based AI-cardiac-diagnostics company, won a 2026 Edison Awards Gold Medal in Precision Health Technologies for its VMS+™ 4.0 system, advanced to regulatory submission in China via partner Lishman Global Inc. on April 28, 2026, and announced deployment partnerships and international conference participation in May 2026.